Carisbamate add-on therapy for drug-resistant focal epilepsy https://t.co/4d4aYl8BRw
RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…
RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…
#Carisbamate add‐on therapy for drug‐resistant focal #epilepsy https://t.co/kBSsdYAOWR - New @CochraneEpileps systematic review looks at the evidence from 4 studies including 2211 participants. https://t.co/o2j1elCXtr
RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…
RT @CochraneLibrary: #Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps syst…
#Carisbamate add‐on therapy for drug‐resistant focal #epilepsy ➡️ https://t.co/ubSHc9dAeN - New @CochraneEpileps systematic review looks at the evidence from 4 studies including 2211 participants. https://t.co/C9XUF4M3RW
Carisbamate add-on therapy for drug-resistant focal epilepsy https://t.co/P1dhxMbVYD